Around 1 in 5 people diagnosed with cancer in the UK take part in a clinical trial.
A study looking at folic acid for women having postmenopausal symptoms (FOAM)
Cancer type:
Breast cancer
Womb (uterine or endometrial) cancer
Status:
Open
Phase:
Phase 3
This study is looking at a drug called folic acid to help manage hot flushes in women who have been through the menopause. It is for women who have had breast cancer, a type of womb cancer called endometrial cancer or women who don’t have cancer.
More about this trial
Hot flushes are a common symptom of 
. They are caused by a fall in the amount of a female hormone called oestrogen. Doctors usually treat hot flushes in post menopausal women with drugs called hormone replacement therapy (). Cancer treatment can cause women to go through the menopause earlier and their symptoms may be worse. There is also the risk that HRT could cause breast or womb cancer to come back. So doctors are looking at other ways to manage hot flushes in this group of women.
In this trial, they are looking at . They are not sure yet how well this will work so they want to find out more. They will also collect blood and urine samples to see what happens to folic acid in the body.
The aims of the trial are find out if folic acid helps to control hot flushes in women who have been through the menopause.
Who can enter
You may be able to join this study if all of the following apply. You
- Have had breast cancer or endometrial cancer and been though an early menopause or you have not had have cancer and been through the menopause
- Are having 50 or more hot flushes a week
- Are between 40 and 70 years old
You cannot join this study if any of these apply
- You had a blood test that shows the level of folic acid in your blood is high or low (outside of the normal range)
- Your kidneys aren’t working properly (the study team can tell you more about this)
- You are taking medication that is known to affect how folic acid works (the study team can tell you more about this)
- You have a condition called Crohn’s disease, coeliac disease, tropical spue or any other digestive problem
- Your body doesn’t make enough red blood cells as you don’t have enough of a vitamin called B12 (this is known as pernicious anaemia)
- You have a condition called phaeochromocytoma, carcinoid syndrome or a type of tumour called a medullary tumour (the study team can tell you more about this)
- You smoke more than 5 cigarettes a day
- You drink a moderate amount of alcohol that could affect you taking part
- You are known to be sensitive or allergic to folic acid
- You have taken part in another clinical trial in the last 4 weeks
Trial design
The study team need 236 women to take part. This is a phase 3 study. It is randomised. The women taking part are put into treatment groups by computer. Neither you nor your doctor will be able to decide which group you are in. And neither of you will know which group you are in. This is called a double blind study.
- One group have folic acid
- The other group have a dummy drug (
placebo )
Folic acid is a tablet. You take 1 folic acid or dummy tablet every day for 3 months.
You will also have a blood and urine test when you start and finish treatment.
The study team will ask you to fill in a questionnaire. The questionnaire will ask about other menopausal symptoms you are having and how you’ve been feeling. This is called a quality of life study. You complete these 4 times during the study.
Hospital visits
Before you start the study you will see the doctor and have some tests. These include
- Measuring your height and weight
- Physical examination
- Blood test (this is to confirm that the level of folic acid in your blood is satisfactory)
You have a trial assessment once a month for a check up while you are having treatment. There is an option to have some assessments by phone instead of visiting hospital. But the first and last assessments must be done in hospital. Each assessment takes about an hour.
Side effects
The side effects of folic acid are minimal. The possible side effects may include an allergic reaction and rarely, a mild stomach upset.
Location
Birmingham
Burton on Trent
Coventry
Macclesfield
Shrewsbury
Solihull
Wolverhampton
Recruitment start:
Recruitment end:
How to join a clinical trial
Please note: In order to join a trial you will need to discuss it with your doctor, unless otherwise specified.
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Chief Investigator
Mr Ayman Ewies
Supported by
NIHR Clinical Research Network: Cancer
Sandwell and West Birmingham Hospitals NHS Trust
University of Birmingham
Questions about cancer? Contact our information nurses
Freephone 0808 800 4040
Last review date
CRUK internal database number:
12941
Please note - unless we state otherwise in the summary, you need to talk to your doctor about joining a trial.
Around 1 in 5 people take part in clinical trials
Last reviewed:
About Cancer generously supported by
Dangoor Education since 2010.
Dangoor Education since 2010.